Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page
- Check6 days agoChange DetectedThe updates appear to be cosmetic adjustments to the page layout (header alignment, spacing, and navigation) with no changes to core study content, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoChange DetectedNo additions or deletions to core study content detected; observed differences appear to be minor visual/layout changes in the page rendering.SummaryDifference0.1%

- Check20 days agoChange DetectedPublication section text updated to clarify that publications are automatically filled from PubMed and may not be about the study, and the revision version updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedThe government funding lapse notice banner on the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedNo significant changes to core content or structure were detected; the page content remains the same with only minor visual formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded posted results to the Study Details page, including results submission/posting dates and key outcomes (ORR, PFS, OS).SummaryDifference0.5%

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.